Historical record - last NADAC effective date: 5/22/2019
Product Information
ACARBOSE 50 MG TABLET is a generic product labeled by Heritage Pharmaceuticals Inc., priced at $0.1968 per EA under NDC 23155014810. Its NADAC has been published 260 times since Jun 4, 2014.
FDA first approved this application on Feb 7, 2012.
The High Outlier badge above means this manufacturer's average price in the Acarbose market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/1
Manufacturer
Heritage Pharmaceuticals Inc.NDC
23155014810
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
5/22/2019
Active Ingredients
ACARBOSEApproval Type
Generic (ANDA)
FDA Application
ANDA202271FDA Approved
2/7/2012
On Market Since
4/16/2021
Pharmacological Classes
Price Statistics
The NADAC for ACARBOSE 50 MG TABLET has been published 260 times since Jun 4, 2014, and over the history we have for it it has declined 45.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1968 per EA |
|---|---|
| All-time high | $0.3665 (Oct 15, 2014) |
| All-time low | $0.1543 (Dec 19, 2018) |
| Median price | $0.2733 |
| Average price | $0.2618 |
| Largest weekly change | +28.3% (Aug 22, 2018) |
| Weeks tracked | 260 |
| Tracking since | Jun 4, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-45.1%
Last surveyed May 22, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 14% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Heritage Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acarbose market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Glucosidase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ACARBOSE 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ACARBOSE 50 MG TABLET, manufactured by Heritage Pharmaceuticals Inc., is $0.1968 per EA (NDC 23155014810), effective May 22, 2019.
How has the price of ACARBOSE 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for ACARBOSE 50 MG TABLET has declined 45.1%. It has been tracked across 260 weekly CMS publications since Jun 4, 2014.
What are the highest and lowest recorded NADAC prices for ACARBOSE 50 MG TABLET?
Since Jun 4, 2014, the NADAC for ACARBOSE 50 MG TABLET has ranged from a low of $0.1543 (Dec 19, 2018) to a high of $0.3665 (Oct 15, 2014), with a median of $0.2733 per EA.
Are there cheaper alternatives to ACARBOSE 50 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ACARBOSE 50 MG TABLET, is $0.1691 per EA — about 14% below ACARBOSE 50 MG TABLET.
Who manufactures ACARBOSE 50 MG TABLET?
ACARBOSE 50 MG TABLET (NDC 23155014810) is labeled by Heritage Pharmaceuticals Inc., and CMS classifies it as a generic product.